TY - JOUR
T1 - Characterisation of patients with supine nighttime reflux: observations made with prolonged wireless oesophageal pH monitoring
AU - Oude Nijhuis, Renske A. B.
AU - Sweis, Rami
AU - Abdul-Razakq, Humayra
AU - Schuitenmaker, Jeroen M.
AU - Wong, Terry
AU - Rusu, Radu-Ionut
AU - Oors, Jac.
AU - Smout, Andreas J. P. M.
AU - Bredenoord, Albert J.
N1 - Funding Information: : RON, HAR, RR, TW, JS, JO and AS have no financial or personal competing interests. AB received research funding from Nutricia, Norgine, SST, Thelial and Bayer and received speaker and/or consulting fees from Laborie, EsoCap, Medtronic, Dr. Falk Pharma, Calypso Biotech, Robarts, Reckett Benkiser, Regeneron, AstraZeneca. RS received speaker fees from Falk Pharma, Medtronic, Ethicon, Takeda and is on the advisory board for Falk Pharma and Ethicon. Declaration of personal interests Publisher Copyright: © 2021 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/7
Y1 - 2021/7
N2 - Background: Although nighttime reflux symptoms are common, the presence of nocturnal reflux is seldom confirmed with a standard 24 hours pH study. Aim: To study patients with supine nighttime reflux symptoms using prolonged wireless pH monitoring. Methods: In this retrospective study, patients with typical acid reflux symptoms were studied using 96-h pH monitoring. Patients with nighttime reflux symptoms were compared to those without. Night-to-night variability and diagnostic accuracy of 24-, 48- and 72-hours pH studies compared to the 96-hours “gold standard” were evaluated. Results: Of the 105 included patients (61.9% females; mean age 46.8 ± 14.4 years), 86 (81.9%) reported nighttime reflux symptoms, of which 67.4% had pathological supine nocturnal acid exposure in at least one night. There was high variance in night-to-night acid exposure (94% [IQR0-144]), which was larger than the variance in upright acid exposure (58% [IQR32-88]; P < 0.001). When analysing the first 24 hours of the pH study, 32% of patients were diagnosed with pathological supine nighttime acid exposure versus 51% of patients based upon the 96-hours pH-test. The diagnostic accuracy and yield improved with study duration (P < 0.001). Reflux episodes with a lower nadir pH or longer acid clearance time were more prone to provoke nightly symptoms. Conclusions: The majority of patients with nocturnal reflux symptoms had pathological acid exposure in at least one night of the prolonged pH recording. A high night-to-night variability in acid exposure reduces the clinical value and diagnostic yield of pH monitoring limited to 24 hours. Prolonged testing is a more appropriate diagnostic tool for patients with nocturnal reflux symptoms.
AB - Background: Although nighttime reflux symptoms are common, the presence of nocturnal reflux is seldom confirmed with a standard 24 hours pH study. Aim: To study patients with supine nighttime reflux symptoms using prolonged wireless pH monitoring. Methods: In this retrospective study, patients with typical acid reflux symptoms were studied using 96-h pH monitoring. Patients with nighttime reflux symptoms were compared to those without. Night-to-night variability and diagnostic accuracy of 24-, 48- and 72-hours pH studies compared to the 96-hours “gold standard” were evaluated. Results: Of the 105 included patients (61.9% females; mean age 46.8 ± 14.4 years), 86 (81.9%) reported nighttime reflux symptoms, of which 67.4% had pathological supine nocturnal acid exposure in at least one night. There was high variance in night-to-night acid exposure (94% [IQR0-144]), which was larger than the variance in upright acid exposure (58% [IQR32-88]; P < 0.001). When analysing the first 24 hours of the pH study, 32% of patients were diagnosed with pathological supine nighttime acid exposure versus 51% of patients based upon the 96-hours pH-test. The diagnostic accuracy and yield improved with study duration (P < 0.001). Reflux episodes with a lower nadir pH or longer acid clearance time were more prone to provoke nightly symptoms. Conclusions: The majority of patients with nocturnal reflux symptoms had pathological acid exposure in at least one night of the prolonged pH recording. A high night-to-night variability in acid exposure reduces the clinical value and diagnostic yield of pH monitoring limited to 24 hours. Prolonged testing is a more appropriate diagnostic tool for patients with nocturnal reflux symptoms.
UR - http://www.scopus.com/inward/record.url?scp=85107619510&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/apt.16447
DO - https://doi.org/10.1111/apt.16447
M3 - Article
C2 - 34114652
VL - 54
SP - 144
EP - 152
JO - Alimentary pharmacology & therapeutics
JF - Alimentary pharmacology & therapeutics
SN - 1365-2036
IS - 2
ER -